Chairman, Pharma Xp Consulting Limited and Global Technical Head, Cmc / Pharmaceutical Development, Viiv Healthcare
Christian holds a masters degree in Chemical Engineering from the University of Karlsruhe, Germany, and a PhD in Chemical Engineering from the University of Birmingham, UK.
Christian has been working in the pharmaceutical industry for the past 17 years and is currently Global Technical Head, CMC / Pharmaceutical Development, of ViiV Healthcare, a pharmaceutical company with 100% focus on HIV therapies, which is owned by GlaxoSmithKline, Pfizer & Shionogi. He is also chairman of Pharma XP Consulting Limited, a company providing technical & strategic consultancy to the pharmaceutical sector, for which he served as Managing Director from 2014 to 2016 (until joining the staff of ViiV Healthcare). Prior to this, Christian worked in the Research Laboratories of Merck/MSD (2000-2014), where he was a Senior Principal Scientist, Formulation Sciences group leader, Controlled Release Centre of Excellence leader (2007-2013) and member of the Innovation Strategy Board in Pharmaceutical Sciences & Clinical Supply (2011-2014).
Christian has been active in the scientific community for many years, having presented at many conferences, supervised a number of University research projects (including PhDs) and served on various scientific committees, mainly for the Institution of Chemical Engineers (IChemE), the Royal Society of Chemistry (RSC) and the Controlled Release Society (CRS).
Christian’s primary research interests / expertise are in the areas of powder granulation, particle coating and oral controlled release formulation development, with broad experience in all aspects of oral solid dosage form development.